Pharma

Powering scientific potential.

Talk to Us

HEOR Industry Trends from ISPOR 2024 Europe

The HEOR industry is constantly evolving – from new EU HTA regulations to the impact of AI. Our team recently attended ISPOR Europe in Barcelona, Spain, where John Cook, our Chief Scientific Officer, gave us his take on the compelling topics people were discussing this year.
Read More

Complete HEOR Solutions Now Offered by BioBridges

BioBridges now offers complete Health Economics and Outcomes Research (HEOR) services. HEOR is a field of research that provides real-world data and insights to demonstrate the clinical and economic value of pharmaceutical products and medical devices.
Read More

PharmAlliance Announces Acquisition of CHEORS

CHEORS Acquired by PharmAlliance PharmAlliance Announces the Acquisition of CHEORS   Per the BusinessWire BioBridges is excited to be part of PharmAlliance, a growing pharmaceutical and life sciences services platform....
Read More

Case Study: Cross-Functional Early Clinical Development Support

An emerging cellular therapeutics company was entering phase 1 clinical testing for their lead hematology candidate based on their antibody-coupled T-cell receptor (ACTR) technology. In order to move their vision for a singular therapeutic platform approach to treat many different cancers through the development process, they needed a plan, processes and hands-on support.
Read More

Receive industry insights right in your inbox.